Possible pathway to new therapy for Alzheimer’s disease
(Boston)–Researchers have uncovered an enzyme and a biochemical pathway they believe may lead to the identification of drugs that could inhibit the production of beta-amyloid protein, the toxic initiator of Alzheimer’s disease (AD).
Funding for this study was provided by grants from the Alzheimer’s Association, the Cure Alzheimer’s Fund and the Boston University Alzheimer’s Disease Center. Work at the BU-CMD is supported by R24-753 GM111625.
Click HERE to read more.